A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Effectiveness of vaccines and monoclonal antibodies against respiratory syncytial virus: Generic protocol for register-based cohort study
Tekijät: Poukka Eero, van Roekel Caren, Turunen Topi, Baum Ulrike, Kramer Rolf, Begier Elizabeth, Presser Lance, Teirlinck Anne, Heikkinen Terho, Knol Mirjam, Nohynek Hanna; PROMISE Investigators
Kustantaja: Oxford University Press
Julkaisuvuosi: 2024
Journal: Journal of Infectious Diseases
Tietokannassa oleva lehden nimi: The Journal of Infectious Diseases
Vuosikerta: 229
Numero: Suppl. 1
Aloitussivu: S84
Lopetussivu: S91
ISSN: 0022-1899
eISSN: 1537-6613
DOI: https://doi.org/10.1093/infdis/jiad484
Verkko-osoite: https://doi.org/10.1093/infdis/jiad484
Tiivistelmä
Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.
Currently several immunisation products are being developed against respiratory syncytial virus (RSV) for children, pregnant females and older adults, and some products have already received authorisation. Therefore, studies to monitor the effectiveness of these products are needed in the following years. To assist researchers to conduct post-marketing studies, we developed a generic protocol for register-based cohort studies to evaluate immunisation product effectiveness against RSV-specific and non-specific outcomes. To conduct a study on the basis of this generic protocol the researchers can use any relevant databases or healthcare registers that are available at the study site.